IL105475A - PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS

Info

Publication number
IL105475A
IL105475A IL105475A IL10547593A IL105475A IL 105475 A IL105475 A IL 105475A IL 105475 A IL105475 A IL 105475A IL 10547593 A IL10547593 A IL 10547593A IL 105475 A IL105475 A IL 105475A
Authority
IL
Israel
Prior art keywords
dehydro
dihydroxy
vitamin
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL105475A
Other languages
English (en)
Other versions
IL105475A0 (en
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of IL105475A0 publication Critical patent/IL105475A0/xx
Publication of IL105475A publication Critical patent/IL105475A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL105475A 1992-04-24 1993-04-21 PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS IL105475A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87337492A 1992-04-24 1992-04-24

Publications (2)

Publication Number Publication Date
IL105475A0 IL105475A0 (en) 1993-08-18
IL105475A true IL105475A (en) 1997-06-10

Family

ID=25361517

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105475A IL105475A (en) 1992-04-24 1993-04-21 PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS

Country Status (10)

Country Link
US (1) US5395830A (fr)
EP (1) EP0567352B1 (fr)
JP (1) JP2769960B2 (fr)
KR (1) KR940005275A (fr)
AT (1) ATE135220T1 (fr)
AU (1) AU666529B2 (fr)
CA (1) CA2094424C (fr)
DE (1) DE69301750T2 (fr)
IL (1) IL105475A (fr)
NZ (1) NZ247406A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
US5661140A (en) * 1994-11-21 1997-08-26 Wisconsin Alumni Research Foundation 18-nor-vitamin D compounds
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
KR100474517B1 (ko) * 1997-10-27 2005-07-21 삼성전자주식회사 엘씨디패널절단장치
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
WO2001022934A2 (fr) * 1999-09-24 2001-04-05 Yng Wong Quing Non Apport de faibles doses de traitement par ingestion
WO2006060884A1 (fr) * 2004-12-06 2006-06-15 K.U. Leuven Research & Development 7-(2-cyclohexylidene-ethylidene)-spiro[4,5]decanes
DK1993375T3 (en) 2006-03-10 2017-07-17 Dsm Ip Assets Bv Hitherto UNKNOWN USE OF NUTRACEUTIC COMPOSITIONS IN ANIMAL FEED.
MX339746B (es) 2009-01-27 2016-06-08 Berg Llc Vitamina d3 y análogos de la misma para aliviar efectos secundarios asociados con la quimioterapia.
JP5978130B2 (ja) 2009-08-14 2016-08-24 バーグ エルエルシー 脱毛症を治療するためのビタミンｄ３およびその類似体
WO2014194133A1 (fr) 2013-05-29 2014-12-04 Berg Llc Prévention ou atténuation de l'alopécie induite par la chimiothérapie au moyen de vitamine d

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833622A (en) * 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
US3901928A (en) * 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4267117A (en) * 1978-06-19 1981-05-12 The Upjohn Company Compounds and process
US4255596A (en) * 1980-02-25 1981-03-10 Gulf Research & Development Company Preparation of ethylene glycol from ethylene
JPS6089422A (ja) * 1983-10-24 1985-05-20 Kureha Chem Ind Co Ltd 抗骨粗鬆症剤
US4719204A (en) * 1984-03-05 1988-01-12 Wisconsin Alumni Research Foundation Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4822609A (en) * 1984-12-21 1989-04-18 The Procter & Gamble Company Treatment of osteoporosis
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass
US5001118A (en) * 1986-12-29 1991-03-19 Kureha Kagaku Kogyo Kabushiki Kaisha Method for preventing senescence and increasing bone mass
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
CA2010982C (fr) * 1989-02-28 2000-06-13 Toshio Matsumoto Promotion de l'osteogenese par l'utilisation de derives de vitamine d

Also Published As

Publication number Publication date
NZ247406A (en) 1999-05-28
CA2094424C (fr) 2001-01-02
JPH0624992A (ja) 1994-02-01
US5395830A (en) 1995-03-07
AU666529B2 (en) 1996-02-15
AU3689193A (en) 1993-10-28
KR940005275A (ko) 1994-03-21
CA2094424A1 (fr) 1993-10-25
JP2769960B2 (ja) 1998-06-25
DE69301750D1 (de) 1996-04-18
IL105475A0 (en) 1993-08-18
ATE135220T1 (de) 1996-03-15
EP0567352A1 (fr) 1993-10-27
EP0567352B1 (fr) 1996-03-13
DE69301750T2 (de) 1996-07-25

Similar Documents

Publication Publication Date Title
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
WO1994027589A3 (fr) Forme galenique d'un antidepresseur
AU2711295A (en) Combination treatment for inhibiting bone loss
GB9410987D0 (en) High dosage pharmaceutical compositions
AU2553992A (en) Bone-growth-stimulating composition
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
PL303937A1 (en) Application of an antiestrogen compound and pharmaceutical agent
UA41355C2 (uk) Засіб для лікування нейро-сніду
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU1866888A (en) Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
IL101245A0 (en) Pharmaceutical compositions for the treatment of prostatic cancer
CA2135709A1 (fr) Derives de melatonine servant au traitement des troubles du sommeil
IL111579A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating desynchronization disorders
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
IL105474A0 (en) Pharmaceutical compositions containing 1alpha,25-dihydroxy-22(e)-dehydrovitamin d3 for treating osteoporosis
AU1188492A (en) Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
EP0618812A4 (fr) Utilisation de la protease nexine-i comme anti-inflammatoire.
CA2136140A1 (fr) Agent carcinostatique pour hormonotherapie dont dienogest est la composante efficace
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
EP0653208A3 (fr) Antagonistes de la substance P pour le traitement et la prévention de l'erythème solaire.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force